{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:11:27Z","timestamp":1792714287321,"version":"4.5.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211138\/Z\/18\/Z"],"award-info":[{"award-number":["211138\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Antibodies that can bind to viruses but are unable to block infection in cell culture are known as \u201cnonneutralizing antibodies.\u201d Such antibodies are nearly universally elicited following viral infection and have been characterized in viral infections such as influenza, rotavirus, cytomegalovirus, HIV, and SARS-CoV-2. It has been widely assumed that these nonneutralizing antibodies do not function in a protective way in vivo and therefore are not desirable targets of antiviral interventions; however, increasing evidence now shows this not to be true. Several virus-specific nonneutralizing antibody responses have been correlated with protection in human studies and also shown to significantly reduce virus replication in animal models. The mechanisms by which many of these antibodies function is only now coming to light. While nonneutralizing antibodies cannot prevent viruses entering their host cell, nonneutralizing antibodies work in the extracellular space to recruit effector proteins or cells that can destroy the antibody-virus complex. Other nonneutralizing antibodies exert their effects inside cells, either by blocking the virus life cycle directly or by recruiting the intracellular Fc receptor TRIM21. In this review, we will discuss the multitude of ways in which nonneutralizing antibodies function against a range of viral infections.<\/jats:p>","DOI":"10.1371\/journal.ppat.1011670","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T17:23:03Z","timestamp":1696526583000},"page":"e1011670","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Protective mechanisms of nonneutralizing antiviral antibodies"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6299-9436","authenticated-orcid":true,"given":"Tawny L.","family":"Chandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9790-7420","authenticated-orcid":true,"given":"Sarah L.","family":"Caddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"ppat.1011670.ref001","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/297070a0","article-title":"Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis","volume":"297","author":"AL Schmaljohn","year":"1982","journal-title":"Nature"},{"key":"ppat.1011670.ref002","doi-asserted-by":"crossref","first-page":"37341","DOI":"10.1038\/srep37341","article-title":"Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.","volume":"6","author":"JH Kim","year":"2016","journal-title":"Sci Rep."},{"key":"ppat.1011670.ref003","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"ppat.1011670.ref004","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"CS Nelson","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"ppat.1011670.ref005","doi-asserted-by":"crossref","first-page":"e156827","DOI":"10.1172\/JCI156827","article-title":"Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection","volume":"132","author":"EC Semmes","year":"2022","journal-title":"J Clin Invest"},{"key":"ppat.1011670.ref006","article-title":"ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection.","author":"EC Semmes","year":"2023","journal-title":"Infectious Diseases (except HIV\/AIDS);"},{"issue":"181","key":"ppat.1011670.ref007","first-page":"4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"2008","author":"DM Carragher","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"ppat.1011670.ref008","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/eji.201343565","article-title":"Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and Fc\u03b3R: Immunity to infection","volume":"43","author":"T Straub","year":"2013","journal-title":"Eur J Immunol"},{"key":"ppat.1011670.ref009","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/eji.201343566","article-title":"Non-neutralizing antibodies protect from chronic LCMV infection independently of activating Fc\u03b3R or complement: Immunity to infection","volume":"43","author":"K Richter","year":"2013","journal-title":"Eur J Immunol"},{"key":"ppat.1011670.ref010","doi-asserted-by":"crossref","first-page":"eaaw9535","DOI":"10.1126\/sciadv.aaw9535","article-title":"GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection.","volume":"5","author":"JW Golden","year":"2019","journal-title":"Sci Adv."},{"key":"ppat.1011670.ref011","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes Involved in Antibody-Mediated Protection from Ebola Virus","volume":"287","author":"JA Wilson","year":"2000","journal-title":"Science"},{"key":"ppat.1011670.ref012","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chom.2020.03.025","article-title":"Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies","volume":"27","author":"PA Ilinykh","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ppat.1011670.ref013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1348-0421.1990.tb01002.x","article-title":"Protection of mice against Sendai virus pneumonia by non-neutralizing anti-F monoclonal antibodies","volume":"34","author":"Y Mochizuki","year":"1990","journal-title":"Microbiol Immunol"},{"key":"ppat.1011670.ref014","doi-asserted-by":"crossref","first-page":"2149352","DOI":"10.1080\/22221751.2022.2149352","article-title":"Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism","volume":"12","author":"R Du","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"ppat.1011670.ref015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162282","article-title":"Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody","volume":"132","author":"T Dangi","year":"2022","journal-title":"J Clin Invest"},{"key":"ppat.1011670.ref016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/jvi.59.1.168-171.1986","article-title":"Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice","volume":"59","author":"K Nakanaga","year":"1986","journal-title":"J Virol"},{"issue":"Pt 6)","key":"ppat.1011670.ref017","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1099\/0022-1317-64-6-1405","article-title":"Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis","volume":"64","author":"WA Boere","year":"1983","journal-title":"J Gen Virol"},{"key":"ppat.1011670.ref018","doi-asserted-by":"crossref","first-page":"108962","DOI":"10.1016\/j.celrep.2021.108962","article-title":"The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies","volume":"35","author":"JT Earnest","year":"2021","journal-title":"Cell Rep"},{"key":"ppat.1011670.ref019","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc \u03b3 Receptor-Dependent and -Independent Mechanisms","volume":"80","author":"KM Chung","year":"2006","journal-title":"J Virol"},{"key":"ppat.1011670.ref020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/0022-1317-67-3-591","article-title":"Neutralizing (54K) and Non-neutralizing (54K and 48K) Monoclonal Antibodies against Structural and Non-structural Yellow Fever Virus Proteins Confer Immunity in Mice.","volume":"67","author":"EA Gould","year":"1986","journal-title":"J Gen Virol"},{"key":"ppat.1011670.ref021","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model.","volume":"9","author":"MJ Bailey","year":"2018","journal-title":"Nat Commun."},{"key":"ppat.1011670.ref022","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-5728(87)90093-2","article-title":"Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication","volume":"15","author":"JT Harty","year":"1987","journal-title":"J Neuroimmunol"},{"key":"ppat.1011670.ref023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.272.5258.104","article-title":"Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity","volume":"272","author":"JW Burns","year":"1996","journal-title":"Science"},{"key":"ppat.1011670.ref024","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/iai.37.3.1132-1137.1982","article-title":"Protection against lethal challenge of BALB\/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2","volume":"37","author":"N Balachandran","year":"1982","journal-title":"Infect Immun"},{"key":"ppat.1011670.ref025","doi-asserted-by":"crossref","first-page":"e1006601","DOI":"10.1371\/journal.ppat.1006601","article-title":"Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.","volume":"13","author":"A Bootz","year":"2017","journal-title":"PLoS Pathog."},{"key":"ppat.1011670.ref026","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DJ DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"ppat.1011670.ref027","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"AJ Hessell","year":"2007","journal-title":"Nature"},{"key":"ppat.1011670.ref028","author":"ME Ackerman","year":"2014","edition":"1"},{"key":"ppat.1011670.ref029","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/cyto.a.24552","article-title":"Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation.","volume":"101","author":"D Mielke","year":"2022","journal-title":"Cytometry A."},{"key":"ppat.1011670.ref030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cyto.a.21084","article-title":"High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.","volume":"79A","author":"J Pollara","year":"2011","journal-title":"Cytometry A"},{"key":"ppat.1011670.ref031","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/infdis\/160.5.770","article-title":"Neonatal Antibody-Dependent Cellular Cytotoxic Antibody Levels Are Associated with the Clinical Presentation of Neonatal Herpes Simplex Virus Infection","volume":"160","author":"S Kohl","year":"1989","journal-title":"J Infect Dis"},{"key":"ppat.1011670.ref032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.","volume":"10","author":"EA van Erp","year":"2019","journal-title":"Front Immunol"},{"key":"ppat.1011670.ref033","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41392-021-00759-1","article-title":"Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients.","volume":"6","author":"Y Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ppat.1011670.ref034","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies","volume":"190","author":"S Jegaskanda","year":"2013","journal-title":"J Immunol"},{"key":"ppat.1011670.ref035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12977-021-00568-y","article-title":"Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG.","volume":"18","author":"H Md Zahid","year":"2021","journal-title":"Retrovirology"},{"key":"ppat.1011670.ref036","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cei.12962","article-title":"Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56+ natural killer cell responses in chronic HCV-infected patients.","volume":"189","author":"L Long","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"ppat.1011670.ref037","doi-asserted-by":"crossref","first-page":"eabp9770","DOI":"10.1126\/sciadv.abp9770","article-title":"Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity.","volume":"8","author":"AD L\u00f3pez-Mu\u00f1oz","year":"2022","journal-title":"Sci Adv."},{"key":"ppat.1011670.ref038","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fimmu.2019.00332","article-title":"Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses.","volume":"10","author":"MZ Tay","year":"2019","journal-title":"Front Immunol."},{"key":"ppat.1011670.ref039","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.016","article-title":"A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples","volume":"366","author":"ME Ackerman","year":"2011","journal-title":"J Immunol Methods"},{"key":"ppat.1011670.ref040","doi-asserted-by":"crossref","first-page":"113328","DOI":"10.1016\/j.jim.2022.113328","article-title":"A multifaceted high-throughput assay for probing antigen-specific antibody-mediated primary monocyte phagocytosis and downstream functions","volume":"510","author":"T Zohar","year":"2022","journal-title":"J Immunol Methods"},{"key":"ppat.1011670.ref041","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.3390\/ijms22158206","article-title":"Analysis and Fine Specificity of the HCMV-Specific Cell-Free and Cell-Associated Antibody-Dependent Cellular Phagocytosis (ADCP) Responses in Lung Transplant Recipients.","volume":"22","author":"S Eberhard","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ppat.1011670.ref042","doi-asserted-by":"crossref","first-page":"678511","DOI":"10.3389\/fimmu.2021.678511","article-title":"Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques.","volume":"12","author":"J Pollara","year":"2021","journal-title":"Front Immunol."},{"key":"ppat.1011670.ref043","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.10.052","article-title":"Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.","volume":"183","author":"T Zohar","year":"2020","journal-title":"Cell"},{"key":"ppat.1011670.ref044","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection","volume":"19","author":"CJ Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ppat.1011670.ref045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01450","article-title":"Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.","volume":"11","author":"J Mellors","year":"2020","journal-title":"Front Immunol"},{"key":"ppat.1011670.ref046","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1128\/JVI.05859-11","article-title":"Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In vivo via Fcy receptor and complement-dependent effector mechanisms","volume":"85","author":"MR Vogt","year":"2011","journal-title":"J Virol"},{"key":"ppat.1011670.ref047","first-page":"413","article-title":"Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus.","volume":"19","author":"KA Howell","year":"2017","journal-title":"CellReports"},{"key":"ppat.1011670.ref048","doi-asserted-by":"crossref","first-page":"110368","DOI":"10.1016\/j.celrep.2022.110368","article-title":"A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection","volume":"38","author":"G Beaudoin-Bussi\u00e8res","year":"2022","journal-title":"Cell Rep"},{"key":"ppat.1011670.ref049","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semcdb.2021.10.010","article-title":"Virus neutralisation by intracellular antibodies","volume":"126","author":"M Bottermann","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"ppat.1011670.ref050","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1172\/JCI14397","article-title":"Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6\u2013specific IgA mAb","volume":"109","author":"N Feng","year":"2002","journal-title":"J Clin Invest"},{"key":"ppat.1011670.ref051","doi-asserted-by":"crossref","first-page":"e1008732","DOI":"10.1371\/journal.ppat.1008732","article-title":"Intracellular neutralisation of rotavirus by VP6-specific IgG.","volume":"16","author":"SL Caddy","year":"2020","journal-title":"PLoS Pathog"},{"key":"ppat.1011670.ref052","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1073\/pnas.0609174104","article-title":"Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.","volume":"104","author":"LC James","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"ppat.1011670.ref053","first-page":"40","article-title":"Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity","author":"SL Caddy","year":"2021","journal-title":"EMBO J"},{"key":"ppat.1011670.ref054","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/eji.202049068","article-title":"Non-neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice","volume":"51","author":"D Stoycheva","year":"2021","journal-title":"Eur J Immunol"},{"key":"ppat.1011670.ref055","doi-asserted-by":"crossref","first-page":"e1003207","DOI":"10.1371\/journal.ppat.1003207","article-title":"Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity","volume":"9","author":"BJ Laidlaw","year":"2013","journal-title":"PLoS Pathog"},{"key":"ppat.1011670.ref056","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imm.12861","article-title":"Prospects from systems serology research","volume":"153","author":"KB Arnold","year":"2018","journal-title":"Immunology"},{"key":"ppat.1011670.ref057","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"X Qiu","year":"2014","journal-title":"Nature"},{"key":"ppat.1011670.ref058","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-021-04017-w","article-title":"Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy","volume":"599","author":"R Yamin","year":"2021","journal-title":"Nature"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T17:23:32Z","timestamp":1696526612000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011670"}},"subtitle":[],"editor":[{"given":"Matthew J.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1011670","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}